Opal Therapeutics secures a $1.25M investment to enhance its laboratory infrastructure and patient-derived organoid manufacturing.
Amount Raised
$1.25 Million
Round Type
Grant
San FranciscoBiotechnologyHealth CareTherapeuticsInvestors
Description
Opal Therapeutics, based in San Francisco, CA, has received a $1.25M investment from the National Science Foundation. The funds will be used to scale laboratory infrastructure and expand internal datasets. The company focuses on therapeutic development in women's gynecological health. They utilize a platform that isolates cells from menstrual blood to create organoid models for disease research.
Quick answer
Opal Therapeutics raised $1.25 Million in a Grant round, dated August 7, 2026. Investors: National Science Foundation. Opal Therapeutics is based in San Francisco, California, United States.
- How much did Opal Therapeutics raise?
- Opal Therapeutics raised $1.25 Million in a Grant round on August 7, 2026.
- Who invested in Opal Therapeutics?
- National Science Foundation is named as investors in this round.
- What does Opal Therapeutics do?
- Opal Therapeutics is a biotechnology company focused on enabling treatments and diagnostics for chronic diseases in women’s reproductive health, including endometriosis, fibroids, PCOS, and heavy menstrual bleeding.
- Where is Opal Therapeutics based and how big is it?
- Opal Therapeutics is based in San Francisco, California, United States. Fundz records about 6 employees.
- Who are the decision-makers at Opal Therapeutics?
- Fundz holds 1 contact at Opal Therapeutics, including the Chief Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Opal Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Novadip Biosciences raised $12M (Convertible Note) on September 21, 2026.
- Anacalypsis Therapeutics raised an undisclosed amount (Pre-Seed) on September 21, 2026.
- Navigator Medicines raised $10M on September 18, 2026.
- Big Picture Bio raised $2M (Pre-Seed) on September 18, 2026.
- Matisse Pharmaceuticals B.V raised $16M (Series A) on September 17, 2026.
- Lisata Therapeutics raised $352M (Series C) on September 17, 2026.
Who to call at Opal Therapeutics, and when
A new round usually means Opal Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Opal Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Opal Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Opal Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Opal Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Opal Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.